In vitro studies on transdermal permeation of butorphanol

Drug Development and Industrial Pharmacy

Volumn 33, Issue 5, 2007, Pages 559-567

  Svozil, Michal ^a   Doležal, Pavel ^a   Hrabálek, Alexander ^a   Měrička, Pavel ^b  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Butorphanol; Laurocapram; Skin permeation enhancement; Transdermal delivery; Transkarbam 12

Indexed keywords

BUFFER; BUTORPHANOL; CARBAMIC ACID DERIVATIVE; LAUROCAPRAM; MYRISTIC ACID ISOPROPYL ESTER; PENETRATION ENHANCING AGENT; TRANSKARBAM 12; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SYNTHESIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PH; SKIN; STATISTICAL ANALYSIS;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; AZEPINES; BUTORPHANOL; CARBAMATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXCIPIENTS; HUMANS; HYDROGEN-ION CONCENTRATION; MYRISTATES; PERMEABILITY; SKIN; SKIN ABSORPTION; SOLUBILITY; VEHICLES;

EID: 34249337738     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040601128639     Document Type: Article

References (28)

1. Aungst, B. J., Blake, J. A., Rogers, N. J., & Hussain, M. A. (1990). Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles. J. Pharm. Sci., 79(12), 1072-1076.
2. Barry, B. W. (1987). Penetration enhancers. Mode of action in human skin. In Shroot, B., Schaefer, H. (Eds.), Pharmacology of the skin. Karger, Basel, pp. 121-137.
3. Bouwstra, J. A., Dubbelaar, F. E. R., Gooris, G. S., Weerheim, A. M., & Ponec, M. (1999). The role of ceramide composition in the lipid organisation of the skin barrier. Bioch. Biophys. Acta, 1419(2), 127-136.
4. Budd, K. (2003). Buprenorphine and the transdermal system: the ideal match in pain management. Int. J. Clin. Pract., 133, 9-15.
5. Bunge, A. L., & Cleek, R. L. (1995). A new method for estimating dermal absorption from chemical exposure. Effect of molecular weight and octanol water partitioning. Pharm. Res., 12(7), 88-95.
6. Doležal, P., Hrabálek, A., Svozil, M., Vá vrová, K., & Zbytovská, J. (2003). In vitro studies on transkarbam 12 and laurocapram effect on trahsdermal permeation of butorphanol. Farm. Vest., 54, 527-528.
7. Flynn, G. L. (1989). Mechanism of percutaneous absorption from physicochemical evidence, In: Bronaugh, R. L., Maibach, H. I. (Eds.): Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery. Marcel Dekker, New York, 27-51.
8. Fullerton, A., & Christup, L. (1991). Evaluation of the transdermal route for administration of narcotic analgesics: Human skin permeability studies of methadone and pethidine. Acta Pharm. Nord., 3(3), 181-182.
9. Ghosh, T. K., & Bagherian, A. (1996). Development of a transdermal patch of methadone: in vitro evaluation across hairless mouse and human cadaver skin. Pharm. Dev. Technol., 1(3), 285-291.
10. Hadgraft, J., & Valenta, C. (2000). pH, pKa and dermal delivery. Int. J. Pharm., 200(2), 243-247.
11. Hadgraft, J. (1999). Passive enhancement strategies in topical and transdermal drug delivery. Int. J. Pharm., 184(1), 1-6.
12. Homan, R. V. (1994). Transnasal butorphanol. Am. Fam. Physician., 49(1), 188-192.
13. Hrabálek, A., Doležal, P., Farsa, O., Krebs, A., Roman, M., & Šklubalová, Z. (2001). ω-Amino acid derivatives, processes of their preparation and their use. Patent USA 6,187,938, Feb. 13.
14. Hrabálek, A., Doležal, P., Vávrová, K., Zbytovská, J., Holas, T., Klimentová, J., Novotný, J. (2006). Synthesis and enhancing effect of transkarbam 12 on the transdermal delivery of theophylline, clotrimazole, flobufen, and griseofulvin. Pharm. Res., 23(6), 912-919.
15. Jaiswal, J., Poduri, R., & Panchagnula, R. (1999). Transdermal delivery of naloxone: ex vivo permeation studies. Int. J. Pharm., 179(1), 129-134.
16. Jolicoeur, L. M., Nassiri, M. R., Shipman, C., Choi, H. K., & Flynn, G. L. (1992). Etorphine is an opiate analgesic physicochemically suited to transdermal delivery. Pharm. Res., 9(7), 963-965.
17. Pachter, I. J., & Evens, R. (1985). Butorphanol. Drug Alcohol Depend., 14(3-4), 325-338.
18. Panchagnula, R., Salve, P. S., Thomas, N. S., Jain, A. K., & Ramarao, P. (2001). Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int. J. Pharm., 219(1-2), 95-105.
19. Payne, R. (1998). Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain. Seminars In Oncology, 25(3 Suppl. 7), 47-53.
20. Ritschel, W. A., & Hussain, A. S. (1988). The principles of permeation of substances across the skin. Meth. Find. Exptl. Clin. Pharmacol., 10(1), 39-56.
21. Rosow, C. E. (1988). Butorphanol in perspective. Acute Care, 12(Suppl. 1), 2-7.
22. Roy, S. D., & Flynn, G. L. (1989). Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm. Res., 6(10), 825-832.
23. Roy, S. D., & Flynn, G. L. (1990). Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. Pharm. Res., 7(8), 842-847.
24. Roy, S. D., Hou, S. Y., Witham, S. L., & Flynn, G. L. (1994a). Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin. J. Pharm. Sci., 83(12), 1723-1728.
25. Roy, S. D., Sharma, K., & Roos, E. (1994b). Transdermal delivery of buprenorphine through cadaver skin. J. Pharm. Sci., 83(2), 126-130.
26. Roy, S. D., & Flynn, G. L. (1989). Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl and sufentanyl. Pharm. Res., 6(2), 147-151.
27. Vachharajani, N. N., Shyu, W. C., Greene, D. S., & Barbhaiya, R. H. (1997). The pharmacokinetics of butorphanol and its metabolites at steady state following nasal administration in humans. Biopharm. Drug Dispos., 18(3), 191-202.
28. Vogelsang, J., & Hayes, S. R. (1991). Butorphanol tartrate (Stadol): a review. J. Post. Anesth. Nurs., 6(2), 129-135.